FDA approves Keytruda and Padcev combo for bladder cancer treatment
Go back to FDA approves Keytruda and Padcev combo for bladder cancer treatment| Merck & Co. (NYSE: MRK) | Delayed: 125.37 -3.13 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.50 | 52 Week High | $65.46 | |||
| Open | $128.01 | 52 Week Low | $47.97 | |||
| Day High | $128.42 | P/E | 85.29 | |||
| Day Low | $124.71 | EPS | $1.47 | |||
| Volume | 10,761,348 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 23.88 -0.2 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.08 | 52 Week High | $37.39 | |||
| Open | $24.15 | 52 Week Low | $28.25 | |||
| Day High | $24.24 | P/E | 14.47 | |||
| Day Low | $23.74 | EPS | $1.65 | |||
| Volume | 49,375,397 | |||||
